Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Conditions

Inflammation 3Vasculitis 2Uveitis 2Granulomatosis with Polyangiitis 2Arthritis, Juvenile 2Temporomandibular Joint Disorders 1Stomatitis 1Pneumonia 1Neoplasms 1Metabolic Syndrome 1Lupus Nephritis 1Asthma 1Arthritis, Rheumatoid 1

Interventions

Etanercept 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Granulomatosis with Polyangiitis × Etanercept × Clear all
NCT00001901 2008-03-04

Etanercept to Treat Wegener's Granulomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
60 enrolled

Vasculitis, Granulomatosis with Polyangiitis

NCT00005007 2007-12-28

Etanercept for Wegener's Granulomatosis

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Phase 2/3 Completed
181 enrolled

Vasculitis, Granulomatosis with Polyangiitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡